Drug intelligence / Profile preview

Compral

Development stage
Unknown
Lead developer
ADOCK Ingram
Modality
Small Molecules
Administration
Oral
01

Overview

Compral is an over-the-counter analgesic combination product developed and marketed by Adcock Ingram Limited in South Africa. It is a small molecule combination drug containing three active ingredients: aspirin (400mg), paracetamol (100mg), and anhydrous caffeine (30mg). Aspirin acts as a non-steroidal anti-inflammatory drug (NSAID) by irreversibly inhibiting cyclooxygenase (COX) enzymes, providing anti-inflammatory and analgesic effects. Paracetamol (acetaminophen) provides additional analgesic and antipyretic effects, likely through central nervous system mechanisms involving the modulation of prostaglandin synthesis. Caffeine acts as a central nervous system stimulant and an adjuvant to enhance the analgesic efficacy of the other components. Compral is indicated for the symptomatic relief of mild to moderate pain, including headaches, dysmenorrhea, muscle and joint pain, dental pain, fever, and symptoms associated with colds or flu.

Brand names
CompralCompral Pain TabletsCompral Headache TabletsCompral Headache Powders
Other names
aspirin + paracetamol + caffeine
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)ADORA2A (Adenosine A₂A Receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ADORA1 (Adenosine receptor A1 subtype)

Beyond the preview

Go deeper on Compral.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Compral.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call